摘要
目的探讨通关藤苷H(TSH)对人结肠癌LoVo细胞增殖、迁移和凋亡的影响,及其对高尔基磷蛋白3(GOLPH3)的调控作用。方法实验1:分为低、中低、中、高剂量组和对照1组,分别给予0.1,1.0,10.0和100.0μg·mL^(-1) TSH及等量0.9%NaCl干预,处理24,48和72 h;实验2:分为(1)对照2组,0.9%NaCl;(2)TSH组,TSH;(3)空载组,p-CMV-control+0.9%NaCl;(4)GOLPH3组,p-CMV-2-GOLPH3+0.9%NaCl;(5)实验1组,p-CMV-control+TSH;(6)实验2组,p-CMV-2-GOLPH3+TSH;本部分实验的TSH质量浓度均为25μg·mL^(-1),干预24 h,检测细胞增殖活力、GOLPH3及转录活化因子3(ATF3)的表达水平、迁移能力和凋亡情况。结果TSH呈浓度依赖性抑制LoVo细胞增殖。TSH组和对照2组的ATF3蛋白相对表达水平分别为0.08±0.02和1.00±0.15。空载组、TSH组、GOLPH3组、实验1组、实验2组和对照2组的GOLPH3蛋白相对表达量分别为1.00±0.27,0.08±0.06,3.82±0.52,0.17±0.12,3.58±0.55和1.00±0.12,迁移细胞数分别为(301±26),(47±12),(372±55),(39±14),(284±31)和(293±64)个,细胞凋亡率分别为(1.11±0.65)%,(31.77±3.47)%,(0.34±0.35)%,(30.06±4.86)%,(2.27±1.19)%和(0.51±0.54)%。TSH组的GOLPH3、ATF3表达水平、细胞迁移数和细胞凋亡率与对照2组比较,差异均有统计学意义(P<0.05,P<0.01);GOLPH3组的GOLPH3的蛋白表达水平与空载组比较,差异有统计学意义(P<0.05);实验2组中GOLPH3的蛋白表达水平与实验1组比较,差异有统计学意义(P<0.05);实验1组的细胞迁移数、细胞凋亡率与空载组比较,差异均有统计学意义(均P<0.01);实验2组的细胞迁移数、细胞凋亡率与实验1组比较,差异均有统计学意义(均P<0.01)。结论TSH可通过调控GOLPH3的表达,抑制人结肠癌LoVo细胞体外增殖和细胞迁移,并诱导凋亡。
Objective To investigate the effect of Tenacissoside H(TSH)on the proliferation,migration and apoptosis as well as its regulation on Golgi phosphoprotein 3(GOLPH3)expression in human colon cancer LoVo cells.Methods Experiment 1:They were divided into low,middle-low,middle and high dose groups and control 1 group,which were treated with 0.1,1.0,10.0 and 100.0μg·mL^(-1) TSH and the same amount of 0.9%NaCl respectively for 24,48 and 72 hours.Experiment 2:They were divided into(1)control 2 group,0.9%NaCl;(2)TSH group,TSH;(3)empty vector group,p-CMV-control+0.9%NaCl;(4)GOLPH3 group,p-CMV-2-GOLPH3+0.9%NaCl;(5)experimental 1 group,p-CMV-control+TSH;(6)experimental 2 group,p-CMV-2-GOLPH3+TSH;the concentration of TSH in this part of experiment was 25μg·m L^(-1),treatment for 24 h,the cell proliferation activity,the expression of GOLPH3 and Activating transcription factor 3(ATF3),migration ability and apoptosis were detected.Results TSH inhibited LoVo cell proliferation in a concentration dependent manner.The expression levels of ATF3 in TSH group and control 2 group were 0.08±0.02and 1.00±0.15.In empty vector,TSH,GOLPH3,experimental 1,experimental 2 and control 2 groups,the relative expression levels of GOLPH3 protein were 1.00±0.27,0.08±0.06,3.82±0.52,0.17±0.12,3.58±0.55 and1.00±0.12;the number of migrating cells were(301±26),(47±12),(372±55),(39±14),(284±31)and(293±64);the apoptosis rates were(1.11±0.65)%,(31.77±3.47)%,(0.34±0.35)%,(30.06±4.86)%,(2.27±1.19)%and(0.51±0.54)%.The expression levels of GOLPH3 and ATF3,cell migration and apoptosis rate in TSH group were compared with those in control 2 group and the differences were statistically significant(P<0.05,P<0.01).The protein expression levels of GOLPH3 in GOLPH3 group was compared with that in empty vector group and the difference was statistically significant(P<0.05).The protein expression levels of GOLPH3 in experimental 2 group was compared with that in experimental 1 group and the difference was statistically significant(P<0.05).The number of cell migration and apoptosis rate in experimental 1 group was compared with that in empty vector group and the difference was statistically significant(all P<0.01).The number of cell migration and apoptosis rate in experimental 2 group was compared with that in experimental 1 group and the difference was statistically significant(all P<0.01).Conclusion TSH can inhibit the proliferation and migration of human colon cancer LoVo cells in vitro and induce apoptosis by regulating the expression of GOLPH3.
作者
陈志川
邱成志
庄海滨
王春晓
洪钟时
施泽生
CHEN Zhi-chuan;QIU Cheng-zhi;ZHUANG Hai-bin;WANG Chun-xiao;HONG Zhong-shi;SHI Ze-sheng(Department of General Surgery,The Second Affiliated Hospital of Fujian Medical University,Quanzhou 362000,Fujian Province,China;Department of Gastrointestinal Surgery,Quanzhou First Hospital Affiliated to Fujian Medical University,Quanzhou 362000,Fujian Province,China)
出处
《中国临床药理学杂志》
CAS
CSCD
北大核心
2022年第10期1069-1073,共5页
The Chinese Journal of Clinical Pharmacology
基金
福建省自然科学基金资助项目(2020J01202)
福建省中医药科技基金资助项目(2017FJZYLC403)。
关键词
通关藤苷H
结肠癌
高尔基磷蛋白3
转录活化因子3
Tenacissoside H
colon cancer
golgi phosphoprotein 3
activating transcription factor 3